Bahram Valamehr, Chief R&D Officer at FATE THERAPEUTICS INC (FATE), sold 10,841 shares at $46.33 ($503K) on 2022-01-10, disclosed to the SEC on 2022-01-12.
Seasonal sale ($503k) by Chief R&D Officer — this insider has traded FATE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.33 | 5,245 | $243K | 48.4% |
| 2 | $46.33 | 5,245 | $243K | 48.4% |
| 3 | $47.17 | 351 | $17K | 3.3% |
| Total | $46.36 avg | 10,841 | $503K | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |